Mark Plunkett
About Mark Plunkett
Mark Plunkett is a Sr. Director of Development at Veradigm, where he has worked since 2023. He has extensive experience in software engineering and development, having held key roles at companies such as Gizmo5 Technologies, Allscripts, and Printable Technologies.
Current Role at Veradigm
Mark Plunkett currently holds the position of Sr. Director Development at Veradigm, a role he has occupied since 2023. In this capacity, he oversees development initiatives and contributes to the advancement of healthcare IT solutions. His leadership is instrumental in driving the company's strategic objectives and enhancing product offerings.
Previous Experience at Veradigm
Prior to his current role, Mark served as Director of Software Development at Veradigm from 2018 to 2023. During this tenure, he played a significant role in the Veradigm EHR Product Unit, overseeing the development of essential healthcare IT solutions, including ePrescribe Standalone and ePrescribe Integrated. His contributions were vital to the company's product development efforts.
Career History and Roles
Mark has an extensive career in software development and engineering. He worked at Allscripts as Director of Software Development from 2008 to 2018, where he was the primary contact for audit and compliance activities. His earlier roles include VP of Software Engineering at Gizmo5 Technologies, Inc. from 2006 to 2008, and Director of Engineering at Printable Technologies from 2004 to 2006. He began his career as a Software Engineer at US Freightways Logistics from 1995 to 1997.
Education and Expertise
Mark Plunkett earned a Bachelor of Science degree in Industrial Engineering from Northwestern University. His educational background provides a strong foundation for his expertise in software development and engineering, particularly in the healthcare IT sector.
Achievements in Software Development
Throughout his career, Mark has achieved significant milestones in software development. He led the migration of a SaaS-based ePrescribe application to the public Azure cloud, resulting in a geographically redundant solution that saved the company $500,000 annually. Additionally, as a member of the Veradigm Patent Review Board, he developed a patent training program that contributed to 25% of Allscripts' patent submissions in 2018 and 2019.